Information within this announcement is deemed by the Company to constitute
inside information under the Market Abuse Regulations (EU) No. 596/2014 and
Article 7 of the UK version of EU Regulation 596/2014 which forms part of UK law
by virtue of the European Union (Withdrawal) Act 2018.

23 May 2023

Benchmark Holdings plc 

("Benchmark", the "Company" or the "Group")

Second Quarter and Interim results for the six months ended 31 March 2023

Strong Q2 and H1 results continuing track record of quarterly growth and
strategic delivery

Benchmark (LSE: BMK), the aquaculture biotechnology company, announces its
unaudited interim results for the six months ended 31 March 2023 (the "Period"
or "H1 FY23"). The Company also announces its unaudited results for the three
months ended 31 March 2023 ("Q2 FY23") in compliance with the terms of its
unsecured Green bond. 
Financial highlights
o	Excellent H1 FY23 results driven by good performance in all business areas:
o	25% growth in revenues to £98.9m (H1 FY22: £79.2m)
o	39% increase in Adj. EBITDA to £22.1m (H1 FY22: £15.9m) 
o	47% increase in Adj. EBITDA excluding fair value ("FV") movement in biological
assets to £21.8m (H1 FY22: £14.8m):
	Adj. EBITDA margin excluding FV movement in biological assets increased to 22%
(H1 FY22: 19%)
o	193% increase in Adj. Operating profit excluding FV movement in biological
assets to £11.4m (H1 FY22: £3.9m)
o	Further reduction in loss before tax
o	Operating cash inflow £9.5m (H1 FY22: cash inflow of £2.0m)
o	Strong Q2 FY23 performance building on track record of continuous quarterly
improvement:
o	Revenues +13% to £44.4m (Q2 FY22: £39.2m)
o	Adj. EBITDA +32% to £11.1m (Q2 FY22: £8.4m)